Höcker P, Wagner A
Intensive Blood Bank, University Hospital Vienna, Austria.
Infusionsther Klin Ernahr. 1987 Sep;14 Suppl 4:31-5. doi: 10.1159/000226201.
The rate of procedure-related side-effects was evaluated in 11,895 cytaphereses performed with a Haemonetics 30 (H-30) cell processor (2,486 procedures) or with a Haemonetics V-50 (H-50) cell processor (6,813 procedures) or with the Fenwal CS-3000 cell processor (2,596 procedures). The overall rate of side-effects was 7.41% (absolute number 881). There was a significant difference between female and male donors concerning the frequency of hypotension episodes and citrate toxicity related reactions. There were also distinct differences between the single cell separator types concerning the frequency and type of side effects. Hypotension episodes and citrate-related reactions were observed most frequently during cytapheresis with the H-30 (7.65 and 2.96% respectively). Venous access and technical problems appeared more often when the H-50 or the CS-3000 were used. Thus both the H-50 as well as the CS-3000 cell separators allow safe cytapheresis with a low number of side-effects.
对使用Haemonetics 30(H - 30)细胞处理器进行的2486次血细胞分离术、使用Haemonetics V - 50(H - 50)细胞处理器进行的6813次血细胞分离术以及使用Fenwal CS - 3000细胞处理器进行的2596次血细胞分离术相关的操作副作用发生率进行了评估。副作用的总体发生率为7.41%(绝对数为881)。在低血压发作频率和枸橼酸盐毒性相关反应方面,女性和男性献血者之间存在显著差异。不同类型的单细胞分离器在副作用的频率和类型方面也存在明显差异。在使用H - 30进行血细胞分离术期间,低血压发作和枸橼酸盐相关反应最为常见(分别为7.65%和2.96%)。使用H - 50或CS - 3000时,静脉通路和技术问题出现得更为频繁。因此,H - 50和CS - 3000细胞分离器都能实现副作用较少的安全血细胞分离术。